| David Hung, M.D. | President and Chief Executive Officer | FY2025 | |
| Philippe Sauvage | Chief Financial Officer | FY2025 | |
| Gary Hattersley, Ph.D. | Chief Scientific Officer | FY2024 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.